Cite

HARVARD Citation

    Bian, S. et al. (2017). Antibodies Toward Vedolizumab Appear from the First Infusion Onward and Disappear Over Time. Inflammatory bowel diseases. 23 (12), p. . [Online]. 
  
Back to record